skip to content
Skip Navigation
Suven Life Sciences

Contract Research And Manufacturing Services (CRAMS)

Suven's 'CRAMS' provides Innovative process research and development, supplies to clinical trials, rapid response pilot scale manufacture, dedicated commercial manufacturing on an exclusive basis.

Read More..

Drug Discovery & Development Support Services (DDDSS)

Suven Life Sciences provides wide range of Drug Discovery and Development Support Services to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team of scientists.

Read More..

Drug Discovery & Research/Clinical pipeline

Suven discovery research is focused on discovering and developing new chemical entities (NCEs), which are best in class central nervous system therapies for the treatment of a diverse range of disorders.

Read More..

Formulation Development

Suven formulation development center is equipped with State-of-the Art Infrastructure in 110,000 Sft. Facilities for Product Development, Technology Development, Analytical, cGMP Compliant Pilot / Small scale Manufacturing.

Read More..

News/Events

  • Suven Life Sciences secures Product Patents in Canada and Sri Lanka
  • Suven Life Sciences secures Product Patents in New Zealand and Sri Lanka
  • Suven Life Sciences secures Product Patents in China & Eurasia
  • Suven Life Sciences secures Product & Process Patents in Canada and USA
  • Suven’s Income at Rs. 1998 Mn; PAT at Rs. 388 Mn for the quarter ended June 2018
  • Press Release
  • Q1 FY19 Schedule of conference call for Investors
  • Suven Life Sciences secures Product Patents in Mexico and New Zealand
  • Suven at Alzheimer's Association International Conference (AAIC) in Chicago.
  • Suven Life Sciences secures Product Patents in Europe and South Korea
  • Suven Life Sciences secures Product Patents in India, Singapore, South Korea and Israel
  • Suven Life Sciences secures Product Patents in China and USA
  • Suven Life Sciences is participating and presenting in Jefferies Global Healthcare Conference
  • Suven Life Sciences participating at Sleep 2018 at Baltimore, MD. USA.
  • Suven Life Sciences secures Product Patents in New Zealand and USA
  • Suven Life Sciences secures Product Patents in New Zealand and Norway
  • Suven Life Sciences secures Product Patents in Australia and Singapore
  • Suven Revenue up by 15%; PAT up by 28% for the year ended March 2018
  • Q4 FY18 Schedule of conference call for Investors
  • Suven Life Sciences secures Product Patents in Australia, Eurasia and Europe
  • SUVEN’S Pashamylaram’s Unit Successfully completes US FDA Inspection
  • USFDA Inspection
  • Suven Life Sciences secures a Product Patent in Canada.
  • Suven Life Sciences secures Product Patents in Norway, South Korea, and Singapore.
  • Suven Life Sciences secures Product Patents in India and South Korea
  • Suven Life Sciences secures Product Patents in Aripo and South Korea
  • Q3 & 9MFY18 Conference Call Transcript
  • Suven Revenue up by 11.85%; PAT up by 15.38% for 9 months ended December’ 2017
  • Q3 FY18 Schedule of conference call for Investors
  • Suven Life Sciences secures Product Patents in China and Sri Lanka
More >>

Upcoming Events